Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acthar Gel for Chronic Fatigue in Relapsing Multiple Sclerosis
NCT02315872Phase 3Completed
- Start
- May 2015
- Primary completion
- Jun 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of repository corticotropin injection in fatigue. Started May 2015; status: completed.
02
Drugs
repository corticotropin injection
03
Conditions
fatigue
Beyond the preview
Go deeper on NCT02315872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02315872.